Authors:
BERGAN S
RUGSTAD IE
BENTDAL O
SODAL G
HARTMANN A
LEIVESTAD T
STOKKE O
Citation: S. Bergan et al., MONITORED HIGH-DOSE AZATHIOPRINE TREATMENT REDUCES ACUTE REJECTION EPISODES AFTER RENAL-TRANSPLANTATION, Transplantation, 66(3), 1998, pp. 334-339
Citation: S. Bergan, OPTIMIZATION OF AZATHIOPRINE IMMUNOSUPPRESSION AFTER ORGAN-TRANSPLANTATION BY PHARMACOLOGICAL MEASUREMENTS, Biodrugs, 8(6), 1997, pp. 446-456
Authors:
GIVERHAUG T
BERGAN S
LOENNECHEN T
RUGSTAD HE
AARBAKKE J
Citation: T. Giverhaug et al., ANALYSIS OF METHYLATED 6-MERCAPTOPURINE METABOLITES IN HUMAN RED-BLOOD-CELLS - COMPARISON OF 2 METHODS, Therapeutic drug monitoring, 19(6), 1997, pp. 663-668
Authors:
BERGAN S
BENTDAL O
SODAL G
BRUN A
RUGSTAD HE
STOKKE O
Citation: S. Bergan et al., PATTERNS OF AZATHIOPRINE METABOLITES IN NEUTROPHILS, LYMPHOCYTES, RETICULOCYTES, AND ERYTHROCYTES - RELEVANCE TO TOXICITY AND MONITORING INRECIPIENTS OF RENAL-ALLOGRAFTS, Therapeutic drug monitoring, 19(5), 1997, pp. 502-509
Authors:
BERGAN S
RUGSTAD HE
KLEMETSDAL B
GIVERHAUG T
BENTDAL O
SODAL G
HARTMANN A
AARBAKKE J
STOKKE O
Citation: S. Bergan et al., POSSIBILITIES FOR THERAPEUTIC DRUG-MONITORING OF AZATHIOPRINE - 6-THIOGUANINE NUCLEOTIDE CONCENTRATIONS AND THIOPURINE METHYLTRANSFERASE ACTIVITY IN RED-BLOOD-CELLS, Therapeutic drug monitoring, 19(3), 1997, pp. 318-326
Authors:
BERGAN S
RUGSTAD HE
BENTDAL O
HARTMANN A
KLEMETSDAL B
AARBAKKE J
STOKKE O
Citation: S. Bergan et al., MONITORING AZATHIOPRINE THERAPY BY MEASURING ACTIVE METABOLITES IN RENAL-ALLOGRAFT RECIPIENTS, Kidney international, 49(3), 1996, pp. 931-931
Authors:
BERGAN S
RUGSTAD HE
BENTDAL O
SODAL G
HARTMANN A
KLEMETSDAL B
AARBAKKE J
STOKKE O
Citation: S. Bergan et al., OPTIMIZATION OF AZATHIOPRINE THERAPY BY MEASURING 6-THIOGUANINE NUCLEOTIDES AND METHYLATED MERCAPTOPURINE IN RENAL-ALLOGRAFT RECIPIENTS, Transplantation proceedings, 27(6), 1995, pp. 3426-3426
Authors:
BERGAN S
RUGSTAD HE
BENTDAL O
ENDRESEN L
STOKKE O
Citation: S. Bergan et al., KINETICS OF MERCAPTOPURINE AND THIOGUANINE NUCLEOTIDES IN RENAL-TRANSPLANT RECIPIENTS DURING AZATHIOPRINE TREATMENT, Therapeutic drug monitoring, 16(1), 1994, pp. 13-20
Citation: S. Bergan et al., MONITORING OF AZATHIOPRINE TREATMENT BY DETERMINATION OF 6-THIOGUANINE NUCLEOTIDE CONCENTRATIONS IN ERYTHROCYTES, Transplantation, 58(7), 1994, pp. 803-808
Authors:
BRUBAKK O
BERGAN S
PEDERSEN TR
OVERSKEID K
Citation: O. Brubakk et al., DIASTOLIC TIME IN PATIENTS TREATED WITH TIMOLOL OR PLACEBO AFTER ACUTE MYOCARDIAL-INFARCTION, American journal of noninvasive cardiology, 7(4), 1993, pp. 220-224
Authors:
BERGAN S
RUGSTAD HE
STOKKE O
BENTDAL O
FROYSAKER T
BERGAN A
Citation: S. Bergan et al., CYCLOSPORINE-A MONITORING IN PATIENTS WITH RENAL, CARDIAC, AND LIVER-TRANSPLANTS - A COMPARISON BETWEEN FLUORESCENCE POLARIZATION IMMUNOASSAY AND 2 DIFFERENT RIA METHODS, Scandinavian journal of clinical & laboratory investigation, 53(5), 1993, pp. 471-477